Cazanat 40® Cabozantinib Tablets

Cazanat 40 mg contains cabozantinib and is used for selected advanced cancers, including renal cell carcinoma, hepatocellular carcinoma and certain thyroid cancers. It targets proteins involved in cancer cell growth, tumour progression and blood vessel formation

As prescribed by a doctor. Dose and duration depend on the condition being treated and the patient. Do not change the dose without medical advice.

Side effects vary by patient. Common and serious side effects are listed in the pack insert. Contact a doctor if you have severe or unexpected symptoms.

Tell your doctor about other medicines you take, allergies, pregnancy or breastfeeding, and any liver or kidney conditions before use.

Store below 30 °C in a dry place, in the original pack, out of reach of children.